{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:47:27Z","timestamp":1783594047826,"version":"3.55.0"},"reference-count":34,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Women's Health"],"published-print":{"date-parts":[[2015,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Testing women for urogenital\n                      <jats:italic toggle=\"yes\">Neisseria gonorrhoeae<\/jats:italic>\n                      (GC) and\n                      <jats:italic toggle=\"yes\">Chlamydia trachomatis<\/jats:italic>\n                      (CT) is common in sexually transmitted disease (STD) clinics. However, women may not be routinely tested for\n                      <jats:italic toggle=\"yes\">rectal<\/jats:italic>\n                      GC\/CT. This may lead to missed infections in women reporting anal intercourse (AI).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This was a retrospective review of all women who underwent rectal GC\/CT testing from August 2012 to June 2013 at an STD clinic in Columbus, Ohio. All women who reported AI in the last year had a rectal swab collected for GC\/CT nucleic acid amplification testing (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =331). Using log-binomial regression models, we computed unadjusted and adjusted associations for demographic and behavioral factors associated with rectal GC\/CT infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Participants (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =331) were 47% African-American, with median age of 29 years. Prevalence of rectal GC was 6%, rectal CT was 13%, and either rectal infection was 19%. Prevalence of urogenital GC and CT was 7% and 13% respectively. Among women with rectal GC, 14% tested negative for urogenital GC. Similarly, 14% of women with rectal CT tested negative for urogenital CT. In unadjusted analyses, there was increased rectal GC prevalence among women reporting sex in the last year with an injection drug user, with a person exchanging sex for drugs or money, with anonymous partners, and while intoxicated\/high on alcohol or illicit drugs. After multivariable adjustment, no significant associations persisted, but a trend of increased rectal GC prevalence was observed for women &lt;26 years of age (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =0.06) and those reporting sex while intoxicated\/high on alcohol or drugs (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =0.05). For rectal CT, only age &lt;26 years was associated with prevalent infection in unadjusted models; this association strengthened after multivariable adjustment (prevalence ratio: 6.03; 95% confidence interval: 2.29\u201315.90).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Nearly one in five women who reported AI in the last year had rectal GC or CT infection. Urogenital testing alone would have missed 14% of rectal infections. Standardized guidelines would increase rectal GC\/CT testing in women and help detect missed infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jwh.2014.4948","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T16:02:58Z","timestamp":1424275378000},"page":"182-189","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":34,"title":["High Prevalence of Rectal Gonorrhea and Chlamydia Infection in Women Attending a Sexually Transmitted Disease Clinic"],"prefix":"10.1177","volume":"24","author":[{"given":"Jose A.","family":"Bazan","sequence":"first","affiliation":[{"name":"The Ohio State University"},{"name":"Sexual Health Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Carr Reese","sequence":"additional","affiliation":[{"name":"The Ohio State University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allahna","family":"Esber","sequence":"additional","affiliation":[{"name":"The Ohio State University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Lahey","sequence":"additional","affiliation":[{"name":"The Ohio State University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Ervin","sequence":"additional","affiliation":[{"name":"Sexual Health Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Davis","sequence":"additional","affiliation":[{"name":"The Ohio State University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Fields","sequence":"additional","affiliation":[{"name":"Sexual Health Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail Norris","family":"Turner","sequence":"additional","affiliation":[{"name":"The Ohio State University"},{"name":"The Ohio State University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2015,3,1]]},"reference":[{"key":"e_1_3_3_2_2","first-page":"370","article-title":"CDC grand rounds: Chlamydia prevention: Challenges and strategies for reducing disease burden and sequelae","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC). CDC grand rounds: Chlamydia prevention: Challenges and strategies for reducing disease burden and sequelae. MMWR, 2011; 60:370\u2013373.","journal-title":"MMWR"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/652395"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c1642"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2013-051159"},{"key":"e_1_3_3_6_2","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2010","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR, 2010; 59:1\u2013109.","journal-title":"MMWR"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1370\/afm.337"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2008.008406"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2010.009279"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181d444f6"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31826ae9a2"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181901ccf"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu184"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181a44b8c"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31823b1922"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02398-09"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/0956462413515637"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31828098f8"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2013-051167"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31821890e9"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2013-051248"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181c3ef29"},{"key":"e_1_3_3_23_2","unstructured":"Gen-Probe Inc.. Package insert: APTIMA Combo 2\u00ae Assay (502183EN Rev. A). San Diego CA: Gen-Probe 2010. Available at: www.gen-probe.com\/pdfs\/pi\/502183-EN-RevA.pdf Accessed May13 2014."},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/430704"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2011.011134"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050466"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2008.008211"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2011.010490"},{"key":"e_1_3_3_29_2","first-page":"590","article-title":"Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","unstructured":"Centers for Disease Control and Prevention (CDC). Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR, 2012; 61:590\u201354.","journal-title":"MMWR"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2007.027862"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198107233050404"},{"key":"e_1_3_3_32_2","first-page":"408","article-title":"Prevalence of rectal and pharyngeal infections in women with gonorrhoea in Sheffield","volume":"55","author":"Kinghorn GR","year":"1979","unstructured":"Kinghorn GR, , Rashid S. Prevalence of rectal and pharyngeal infections in women with gonorrhoea in Sheffield. Br J Vener Dis, 1979; 55:408\u2013410.","journal-title":"Br J Vener Dis"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000190092.59482.96"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00100-07"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2009.009440"}],"container-title":["Journal of Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jwh.2014.4948","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2014.4948","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2014.4948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:41:53Z","timestamp":1777657313000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jwh.2014.4948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.1089\/jwh.2014.4948"],"URL":"https:\/\/doi.org\/10.1089\/jwh.2014.4948","relation":{},"ISSN":["1540-9996","1931-843X"],"issn-type":[{"value":"1540-9996","type":"print"},{"value":"1931-843X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}